Clinical Trial

Adaptive Optics Imaging of Outer Retinal Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-04-25; most recent amendment 2026-05-06.
Trial Details
NCT Number NCT05355415
Lead Sponsor Food and Drug Administration (FDA)
Collaborators: National Eye Institute (NEI)
Conditions Retinal Degeneration, Age-Related Macular Degeneration, Retinitis Pigmentosa, Hydroxychloroquine Retinopathy, Usher Syndromes, Late-Onset Retinal Degeneration, Cone Dystrophy, Cone Rod Dystrophy +2 more
Enrollment 100 participants
Start Date 2021-08-27
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-08